Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III factorial trial of radiotherapy volume with or without synchronous 5-fluorouracil and mitomycin in muscle-invasive bladder cancer
ISRCTN68324339Phase 3Completed
- Sponsor
- Individual sponsor
- Start
- Aug 2001
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and mitomycin c in bladder cancer (4 arms), sponsored by Individual sponsor. Primary endpoint: Loco-regional disease-free survival. Started Aug 2001; status: completed.
02
Drugs
fluorouracilmitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on ISRCTN68324339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68324339.